Tertiary Hyperparathyroidism Explained: Autonomous PTH Secretion in CKD, Hypercalcemia and Treatment

What Is Tertiary Hyperparathyroidism?

Central Concept

Phosphate retention + calcitriol ↓ + disturbed Ca balance

Persistent parathyroid stimulation

Progressive loss of normal feedback sensitivity

often:

The defining concept is:

Prolonged CKD-associated SHPT can produce increasingly autonomous parathyroid hyperplasia; this may persist after kidney transplantation despite major correction of the original CKD-related biochemical stimulus. (MDPI)

Central Memory Rule

Use a prominent callout:

Secondary hyperparathyroidism

Tertiary hyperparathyroidism

Primary hyperparathyroidism

Final line:

Opening Article Content

Use the following complete content.

Tertiary hyperparathyroidism is a state of excessive PTH secretion that develops after prolonged secondary hyperparathyroidism, most characteristically in patients with advanced chronic kidney disease.

Initially, increased PTH in CKD is an adaptive response.

The kidneys become progressively less able to maintain normal phosphate and vitamin D physiology. Reduced calcitriol activity, phosphate abnormalities and disturbances in calcium balance stimulate the parathyroid glands.

The result is:

At this stage, the increased PTH is fundamentally a response to another disease.

However, persistent stimulation over years can produce progressive parathyroid enlargement and hyperplasia.

Eventually, some enlarged parathyroid tissue becomes much less responsive to the normal regulatory signals that should suppress PTH secretion.

The result is:

that can continue even when the original stimulus has been substantially corrected.

This state is traditionally called:

The classic clinical example is a patient with long-standing CKD-associated secondary hyperparathyroidism who receives a functioning kidney transplant but continues to have:

and develops or maintains:

because enlarged parathyroid glands continue secreting excessive PTH despite improved renal physiology. (MDPI)

Important Terminology Warning

Include this section early.

The terminology is not completely uniform.

Terms used in the literature include:

• tertiary hyperparathyroidism;
• persistent hyperparathyroidism after kidney transplantation;
• persistent post-transplant hyperparathyroidism;
• hypercalcemic post-transplant hyperparathyroidism.

These terms overlap but are not necessarily identical.

Persistent PTH elevation after transplantation does not automatically prove complete parathyroid autonomy.

Some secondary hyperparathyroidism gradually regresses after successful transplantation.

Therefore:

Interpret:

• calcium;
• phosphate;
• renal graft function;
• PTH trajectory;
• time since transplantation;
• previous severity of SHPT;
• medication exposure.

Recent literature continues to emphasize heterogeneous definitions of persistent and tertiary post-transplant HPT. (PubMed Central (PMC))

How CKD Causes Secondary Hyperparathyroidism

Start With Normal Pth Physiology

PTH is secreted by the parathyroid glands in response to changes in extracellular ionized calcium.

When calcium falls:

PTH acts to defend extracellular calcium by:

• increasing renal calcium reabsorption;
• decreasing renal phosphate reabsorption;
• increasing phosphaturia;
• stimulating renal calcitriol production when renal function permits;
• influencing bone remodeling.

When calcium rises:

This feedback relationship is essential for understanding tertiary HPT.

Calcium Homeostasis

What Happens In Ckd?

As kidney function declines, several abnormalities contribute to secondary HPT.

These include:

• altered phosphate handling;
• reduced renal calcitriol production;
• impaired intestinal calcium absorption through reduced active vitamin D activity;
• changes in FGF23 physiology;
• disturbances in calcium balance;
• progressive parathyroid stimulation.

The result is:

Initially this is:

not autonomous parathyroid disease.

Internal links:

CKD-MBD

Secondary Hyperparathyroidism

Vitamin D Metabolism

Phosphate Homeostasis

Secondary Hyperparathyroidism

Secondary hyperparathyroidism occurs when an external physiological disturbance chronically stimulates otherwise appropriately responding parathyroid tissue.

In CKD:

The gland is responding to the metabolic environment.

Therefore:

KDIGO recommends interpreting PTH together with calcium, phosphate and the broader CKD-MBD pattern rather than reacting to one isolated PTH measurement. (KDIGO)

How Secondary HPT Becomes Autonomous

Why The Parathyroid Glands Enlarge

Persistent stimulation causes:

Initially this can be relatively diffuse.

With prolonged severe disease, enlarged glands may develop:

and increasingly abnormal regulation.

The important concept is:

This is not simply a temporary increase in hormone release.

Progressive Resistance To Normal Feedback

As severe SHPT progresses, parathyroid tissue can become less responsive to regulatory signals.

Important mechanisms include reduced responsiveness involving:

and:

The result is progressively more difficult suppression of PTH.

This helps explain why advanced disease may become resistant to conventional medical treatment and eventually behave autonomously.

From Secondary To Tertiary Hpt

Stage 1

stimulates PTH.

Stage 2

PTH is elevated as compensation.

Stage 3

Persistent stimulation causes:

Stage 4

Advanced hyperplastic tissue becomes:

Stage 5

PTH secretion becomes increasingly:

Stage 6

Even after major correction of the original stimulus:

often causing:

This is the conceptual transition to:

Why Kidney Transplantation Reveals Tertiary HPT

Why Kidney Transplantation Reveals Tertiary Hpt

This is one of the most important sections.

Before transplantation, a patient may have:

After successful kidney transplantation:

phosphate handling improves

calcitriol physiology improves

uremic abnormalities improve.

Therefore:

In many patients, parathyroid hyperplasia gradually regresses.

But in some patients:

This is the classic post-transplant tertiary HPT phenotype. (PubMed Central (PMC))

Why Hypercalcemia Develops

In ordinary CKD-associated secondary HPT, calcium may be normal or low because the elevated PTH is responding to disturbed mineral physiology.

In tertiary HPT:

Therefore PTH can drive:

• renal calcium conservation when graft function permits;
• increased calcitriol-mediated intestinal calcium availability;
• increased skeletal calcium mobilization.

The result may be:

Thus:

after prolonged renal secondary HPT strongly raises concern for autonomous parathyroid secretion.

Why Phosphate May Become Low After Transplantation

This is an important teaching point.

Before transplantation:

CKD may produce:

because renal phosphate excretion is impaired.

After successful transplantation:

renal phosphate excretion improves.

If PTH remains markedly elevated:

Therefore:

can occur.

So the same patient may transition from:

Before transplant

PTH ↑ + PO₄ ↑

to:

After functioning transplant with persistent PTH excess

PTH ↑ + PO₄ ↓

This is not contradictory.

It reflects restoration of the kidney's ability to respond to the phosphaturic action of PTH. Persistent tertiary HPT after transplantation has classically been associated with hypercalcemia and hypophosphatemia. (PubMed Central (PMC))

Typical Biochemical Pattern

Typical pattern in a functioning kidney transplant recipient:

PTH

Calcium

Phosphate

Kidney function

But immediately add:

The biochemical phenotype depends on renal function and clinical context. Tertiary HPT should not be defined solely by one universal calcium, phosphate or PTH threshold.

Tertiary Hpt Before Transplantation?

Tertiary HPT is often taught through the post-transplant example because correction of renal failure makes autonomy easier to recognize.

However, advanced long-standing renal SHPT can become highly autonomous even before transplantation.

Therefore:

Kidney transplantation is not the cause of tertiary HPT.

Rather:

Primary, Secondary and Tertiary Hyperparathyroidism

Secondary Vs Tertiary Hyperparathyroidism

Bottom:

Primary Vs Tertiary Hpt

This distinction is equally important.

Both may produce:

Therefore biochemical values alone may not always tell the entire story.

Primary HPT

The parathyroid abnormality begins as:

usually involving one or more abnormal glands.

Tertiary HPT

The parathyroid abnormality develops after:

usually in CKD.

Therefore the major discriminator is:

Primary Hyperparathyroidism

Secondary Vs Tertiary Vs Primary Hpt Master Table

Use prominently.

Add:

These are characteristic patterns, not absolute rules.

Persistent Hyperparathyroidism After Kidney Transplant

Persistent Hpt After Kidney Transplantation

Persistent PTH elevation after transplantation is common enough that it should not immediately be equated with tertiary HPT.

After transplantation:

because enlarged glands do not necessarily regress immediately.

Therefore evaluate:

• time since transplantation;
• calcium trajectory;
• phosphate;
• graft function;
• pre-transplant PTH severity;
• previous dialysis duration;
• gland size if known;
• calcimimetic exposure.

Recent evidence shows substantial heterogeneity in definitions and timing of post-transplant persistent HPT. (PubMed Central (PMC))

How Common Is Persistent Hpt?

Studies report widely varying rates because they use different:

• PTH thresholds;
• calcium requirements;
• follow-up times;
• populations;
• definitions of tertiary versus persistent HPT.

A recent literature review reports persistent HPT after kidney transplantation in approximately 15–50% of recipients depending on definition and timing, while other cohorts have reported different values. (PubMed Central (PMC))

Use the teaching statement:

Risk Factors For Persistent/Tertiary Disease

Important risk clues include:

• severe pre-transplant SHPT;
• very high pre-transplant PTH;
• long dialysis exposure;
• large/enlarged parathyroid glands;
• nodular hyperplasia;
• previous requirement for calcimimetic therapy;
• persistent hypercalcemia;
• prolonged severe CKD-MBD.

Clinical Manifestations

Patients may be asymptomatic and identified biochemically.

Potential consequences of persistent excessive PTH and hypercalcemia include:

• bone disease;
• bone pain;
• fracture risk;
• hypercalciuria;
• nephrolithiasis;
• nephrocalcinosis;
• soft-tissue calcification;
• vascular calcification;
• possible adverse graft effects.

Persistent post-transplant HPT is associated observationally with adverse patient and graft outcomes, although definitions and causality remain heterogeneous. A 2026 systematic review/meta-analysis found persistent post-transplant HPT associated with higher mortality and graft-failure risks, with stronger graft-risk signals in hypercalcemic phenotypes. (PubMed Central (PMC))

Why The Transplanted Kidney Matters

Persistent hypercalcemia can affect a kidney graft through:

• hypercalciuria;
• nephrolithiasis;
• nephrocalcinosis;
• tubular injury.

Therefore tertiary HPT is not merely an abnormal PTH laboratory result.

The combination:

can have clinically important consequences.

Diagnostic Approach

Diagnostic Approach

Implement this as a major responsive algorithm.

Ca normal

Consider:

• persistent residual secondary HPT;
• CKD-MBD depending graft function;
• vitamin D deficiency;
• gradual parathyroid regression.

Ca high

YES

→ PTH-independent hypercalcemia.

Use general hypercalcemia diagnostic pathway.

NO — PTH HIGH / INAPPROPRIATELY HIGH

Ask:

YES

→ consider:

NO / UNCERTAIN

→ consider:

or another PTH-dependent disorder.

Evaluate:

PO₄ + renal function + history + previous PTH + glandular context

Do Not Diagnose By Imaging

Use a strong teaching box:

Parathyroid imaging can help:

but should not replace biochemical diagnosis.

This follows the same fundamental principle already taught in the Primary Hyperparathyroidism article.

Ultrasound And Nuclear Imaging

When surgery is being planned, localization may use techniques such as:

• neck ultrasound;
• sestamibi-based imaging;
• other advanced imaging according to local surgical practice.

But renal hyperparathyroidism often involves:

Therefore imaging should not be interpreted as though every patient has one isolated adenoma.

Laboratory Assessment

Important investigations include:

Depending on context also consider:

• ionized calcium;
• urinary calcium;
• bone assessment;
• graft evaluation;
• parathyroid imaging if surgery is being considered.

Pth Should Not Be Interpreted Alone

Display:

The same PTH concentration means different things in:

• CKD G5D;
• a functioning kidney transplant;
• hypercalcemia;
• hypocalcemia;
• vitamin D deficiency.

Therefore:

must be interpreted together.

KDIGO explicitly recommends basing CKD-MBD therapeutic decisions on serial assessments of phosphate, calcium and PTH considered together. (KDIGO)

Important Dialysis Pth Nuance

For CKD G5D, KDIGO suggests maintaining intact PTH approximately:

and responding to marked changes within this range rather than trying to normalize PTH completely. (KDIGO)

This recommendation applies to:

It should not be copied as a diagnostic definition of tertiary HPT after kidney transplantation.

This distinction must be explicit.

Treatment Principles

Treatment Principle

Treatment depends on whether the patient is:

• still in advanced CKD/dialysis;
• awaiting transplantation;
• post-transplant;
• hypercalcemic;
• symptomatic;
• medically controlled;
• medically refractory.

The broad treatment options are:

if persistent clinically significant autonomous disease:

Correct Modifiable Factors First

In CKD-associated secondary HPT, evaluate:

• hyperphosphatemia;
• hypocalcemia;
• high phosphate intake;
• vitamin D deficiency.

KDIGO recommends evaluating these modifiable factors when PTH is progressively rising or persistently above the assay upper limit in CKD G3a–G5 not on dialysis. (PubMed Central (PMC))

This matters because:

Phosphate Management

In advanced CKD, phosphate management can involve:

• dietary phosphate strategies;
• phosphate-lowering therapy;
• dialysis phosphate removal where appropriate.

Hyperphosphatemia

or Phosphate Homeostasis if the former does not exist.

Vitamin D And Active Vitamin D

Vitamin D management depends strongly on CKD stage and clinical context.

KDIGO does not recommend routine calcitriol/vitamin-D analogue use for every adult with CKD G3a–G5 not on dialysis; these agents may be reserved for selected patients with severe/progressive hyperparathyroidism in advanced CKD. (KDIGO)

Therefore:

Treatment must follow CKD stage, calcium, phosphate and the broader mineral pattern.

Calcimimetics

Calcimimetics increase sensitivity of the calcium-sensing receptor to extracellular calcium.

This suppresses PTH secretion.

In CKD G5D requiring PTH-lowering therapy, KDIGO includes calcimimetics among recommended therapeutic options. (KDIGO)

In post-transplant persistent hypercalcemic HPT:

is frequently used clinically to reduce:

• calcium;
• PTH;

and may improve hypophosphatemia.

However, post-transplant use has historically often been off-label depending on jurisdiction, and it does not remove autonomous parathyroid tissue. (PubMed Central (PMC))

Calcimimetic Principle

Use:

This can improve biochemical control.

But:

Therefore some patients require long-term therapy or eventually surgery.

Parathyroidectomy

Parathyroidectomy becomes important in:

KDIGO suggests parathyroidectomy in CKD G3a–G5D patients with severe hyperparathyroidism that fails to respond to medical or pharmacological therapy. (KDIGO)

In post-transplant tertiary HPT, surgery may be considered when clinically significant hypercalcemic HPT persists or causes complications despite appropriate medical management.

Surgery Versus Calcimimetic

This should be balanced.

Calcimimetic

Advantages:

• avoids surgery;
• can lower calcium;
• can lower PTH;
• useful for selected patients.

Limitations:

• ongoing treatment may be required;
• disease can recur biochemically after withdrawal;
• autonomous glandular tissue remains.

Parathyroidectomy

Advantages:

• most definitive control of autonomous parathyroid tissue;
• can normalize calcium/PTH more completely in selected patients.

Limitations:

• operative risk;
• postoperative hypocalcemia;
• hungry bone syndrome;
• possible transient changes in graft function;
• possibility of persistent/recurrent disease depending surgical context.

Current evidence suggests surgery provides stronger biochemical control than calcimimetic treatment in established tertiary HPT, but optimal timing and patient selection remain debated. (PubMed)

Timing Of Surgery After Kidney Transplantation

Why?

Because parathyroid tissue may regress after restoration of kidney function.

Therefore immediate surgery for every elevated PTH after transplantation would overtreat some patients.

But prolonged:

with complications or failure of medical control increases the rationale for definitive treatment.

Recent literature suggests potential advantages to earlier intervention in selected severe disease but emphasizes that optimal timing remains uncertain and heterogeneous. (PubMed Central (PMC))

Use:

based on:

severity + duration + Ca + PTH + complications + graft function + medical response

Surgical Approaches

Keep conceptual.

Operations may include:

• subtotal parathyroidectomy;
• total parathyroidectomy with autotransplantation;
• other tailored approaches depending surgical anatomy and institutional practice.

Multigland disease is common.

Hungry Bone Syndrome After Surgery

Major Postoperative Complication: Hungry Bone Syndrome

This provides the important cluster link.

A patient with prolonged severe hyperparathyroidism may have:

After parathyroidectomy:

This is:

Internal link prominently:

Hungry Bone Syndrome Explained

Why Hbs Risk May Be Substantial

Patients requiring parathyroidectomy for severe renal HPT may have:

• very high PTH;
• markedly elevated ALP;
• prolonged high-turnover bone disease.

Therefore their skeleton may have a large mineral deficit.

After surgery:

This explains why postoperative calcium requirements can be substantial.

Persistent Disease After Surgery

Persistent or recurrent HPT may occur because of:

• residual hyperfunctioning tissue;
• supernumerary glands;
• incomplete resection;
• autotransplanted tissue;
• recurrent hyperplasia.

Evaluation depends on:

• postoperative PTH trajectory;
• calcium;
• phosphate;
• operative history;
• imaging when appropriate.

Hypercalcemia Differential and Complications

Hypercalcemia Diagnostic Differential

A kidney transplant recipient with:

does not automatically have tertiary HPT.

Consider:

• tertiary HPT;
• primary HPT;
• medication/context effects;
• familial hypocalciuric hypercalcemia where clinically appropriate.

If:

then tertiary HPT is not the appropriate mechanism.

Instead investigate:

Internal links:

Hypercalcemia Diagnostic Approach

Familial Hypocalciuric Hypercalcemia

Fhh

FHH should not dominate this article.

But if a patient has:

• hypercalcemia;
• nonsuppressed PTH;
• unexpectedly low urinary calcium;
• family history/lifelong hypercalcemia;

consider FHH according to the established diagnostic pathway.

Familial Hypocalciuric Hypercalcemia

Bone Effects

Long-standing excessive PTH can produce:

Possible consequences include:

• bone loss;
• skeletal pain;
• fracture;
• osteitis fibrosa in severe disease.

Following transplantation, bone disease can also reflect:

• previous renal osteodystrophy;
• glucocorticoid exposure;
• persistent HPT;
• osteoporosis;
• other transplant-related factors.

Therefore:

Vascular And Soft-Tissue Calcification

CKD-MBD can promote:

• vascular calcification;
• soft-tissue calcification.

Persistent mineral abnormalities after transplantation may continue to contribute to these risks.

Monitoring After Kidney Transplantation

In the immediate post-transplant period, KDIGO recommends measuring:

After the immediate period, monitoring frequency should depend on:

• CKD stage of the transplant;
• magnitude of abnormalities;
• progression;
• treatment.

PTH and ALP monitoring is individualized according to transplant CKD stage and abnormalities. (PubMed Central (PMC))

Complete Diagnostic Pathway

Implement this large algorithm.

CKD present / dialysis

Correct:

PO₄ / Ca / vitamin D / treatment factors

PTH improves

→ SECONDARY HPT

PTH remains severe/refractory

→ ADVANCED SHPT / POSSIBLE AUTONOMOUS DISEASE

Consider medical intensification / surgery according to severity.

Kidney transplant functioning

Ca normal

→ persistent HPT may still be regressing.

Assess:

time + eGFR + PO₄ + vitamin D + trend

Ca ↑

Yes

→ PTH-independent hypercalcemia

No

Long severe CKD/SHPT history?

Yes

No / uncertain

Medical control where appropriate

Persistent clinically important autonomous disease?

Monitor for:

Worked Clinical Cases

Common Mistakes

Include all 20.

Mistake 1

Tertiary HPT means simply very high PTH.

Wrong.

Mistake 2

Every dialysis patient with severe PTH elevation has tertiary HPT.

Wrong.

Mistake 3

Every high PTH after kidney transplantation is tertiary HPT.

Wrong.

Mistake 4

Secondary and tertiary HPT are distinguished by one universal PTH cutoff.

Wrong.

Mistake 5

Kidney transplantation causes tertiary HPT.

Wrong. Prolonged secondary stimulation produces the abnormal glands; transplantation may reveal persistence/autonomy.

Mistake 6

Secondary HPT is always pathological autonomous secretion.

Wrong. It begins as physiological compensation.

Mistake 7

Tertiary HPT must always have low phosphate.

Wrong. Phosphate depends strongly on renal function.

Mistake 8

Tertiary HPT must always have hypercalcemia in every clinical context.

Wrong. Hypercalcemia is highly characteristic, especially after successful transplant, but definitions and phenotypes vary.

Mistake 9

Primary and tertiary HPT can always be distinguished from one calcium/PTH pair.

Wrong.

Mistake 10

History of CKD automatically proves tertiary HPT.

Wrong.

Mistake 11

Parathyroid imaging makes the diagnosis.

Wrong.

Mistake 12

One enlarged gland proves primary HPT.

Wrong. Renal HPT can involve asymmetric multigland disease.

Mistake 13

PTH should be normalized in every dialysis patient.

Wrong.

Mistake 14

Every elevated PTH in CKD requires calcitriol.

Wrong.

Mistake 15

Calcimimetics surgically cure autonomous parathyroid tissue.

Wrong.

Mistake 16

Every patient with persistent HPT after transplantation needs immediate surgery.

Wrong.

Mistake 17

There is one universally accepted timing for post-transplant parathyroidectomy.

Wrong.

Mistake 18

Parathyroidectomy has no important postoperative metabolic complications.

Wrong.

Mistake 19

Postoperative profound hypocalcemia always means accidental removal of all parathyroid tissue.

Wrong. Hungry bone syndrome is an important alternative.

Mistake 20

One PTH result is enough to understand CKD-related parathyroid disease.

Wrong.

Tertiary Hyperparathyroidism in One Minute

One-Minute Revision

TERTIARY HYPERPARATHYROIDISM IN ONE MINUTE

Classic post-transplant pattern:

with:

Management:

or when refractory/appropriate:

watch for:

Golden Comparison Box

PRIMARY HPT

SECONDARY HPT

TERTIARY HPT

Bottom:

Frequently Asked Questions

Key Take-Home Messages

Tertiary hyperparathyroidism is best understood as the final stage of a physiological progression.

The process begins with:

The abnormal renal mineral environment stimulates:

This produces:

At first, the parathyroid response is adaptive.

But if stimulation continues for years:

and enlarged glands can become increasingly insensitive to the normal signals that should suppress PTH.

Eventually:

Then even when the original stimulus is substantially corrected—classically after successful kidney transplantation—

and:

This is the central concept of:

However, not every persistent PTH elevation after transplantation represents established autonomous disease.

Parathyroid hyperplasia may regress gradually.

Therefore:

and diagnosis requires:

A useful comparison is:

Treatment depends on the clinical setting.

Correct modifiable CKD-MBD abnormalities when relevant.

Use appropriate PTH-lowering medical therapy when indicated.

But when clinically significant autonomous disease persists despite appropriate medical treatment:

And after surgery, always remember:

because the same skeleton that experienced years of high PTH can rapidly become a powerful mineral sink once PTH falls.

Final memory statement: